Estadísticas
Número total de consultas
| Total | |
|---|---|
| Dasatinib, ... | 93 |
Consultas por mes
| abril 2024 | mayo 2024 | junio 2024 | julio 2024 | agosto 2024 | septiembre 2024 | octubre 2024 | |
|---|---|---|---|---|---|---|---|
| Dasatinib, ... | 0 | 2 | 3 | 7 | 7 | 3 | 0 |
Descargas
| Total | |
|---|---|
| Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.pdf | 78 |
| Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.pdf | 1 |
Países con más consultas
| Total | |
|---|---|
| Estados Unidos | 34 |
| Reino Unido | 14 |
| España | 11 |
| Singapur | 9 |
| Alemania | 5 |
| Finlandia | 4 |
| Irlanda | 4 |
| Chequia | 2 |
| México | 2 |
| Suecia | 2 |
Ciudades con más consultas
| Total | |
|---|---|
| Ashburn | 5 |
| Fairfield | 5 |
| Dublin | 4 |
| Oakland | 3 |
| Santa Clara | 3 |
| Sevilla | 3 |
| Helsinki | 2 |
| Lappeenranta | 2 |
| Querétaro City | 2 |
| Redwood City | 2 |